top of page
gradientForSurfBreak.png

Item List

May 3, 2022
PR Newswire
Strados Labs Receives FDA 510(k) Clearance for Home Use of its Smart Sensor Platform

Strados Labs, a medical technology company harnessing the power of smart sensors, machine learning and proprietary algorithms to provide early detection and predictions of worsening respiratory diseases, today announced it has received FDA Class II 510(k) clearance for home use of its first product, RESP®, which make this its second FDA clearance in less than 18 months.

Recent Posts

Portfolio Company

Carlsmed.png

The most innovative healthcare companies of 2026 ...

Fast Company

Mar 24, 2026

Portfolio Company

Carlsmed.png

Stryker, THINK Surgical and Carlsmed Named Winners of 2026 OMTEC Excellence Awar ...

Ortho World

Mar 19, 2026

Portfolio Company

Carlsmed.png

Carlsmed Stands Out Among Surgical Equipment Rivals
...

National Today

Mar 15, 2026

surf break copy_edited_edited.jpg
surbreak-19.png
WM360_logo-18.png
bottom of page